External validation of the pediatric International IgA Nephropathy Prediction Tool in a central China cohort

被引：0
|
作者：
Daojing Ying
Mengke Lu
Yuanzhao Zhi
Peipei Shi
Lu Cao
Qin Wang
Yingying Zhang
Jianjiang Zhang
机构：
[1] The First Affiliated Hospital of Zhengzhou University,Department of Pediatrics
来源：
Clinical and Experimental Nephrology | 2024年 / 28卷
关键词：
Children; External validation; IgA nephropathy; Prediction models;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：59 / 66
页数：7
相关论文
共 50 条
  • [21] The International IgA Nephropathy Network Prediction Tool Underestimates Disease Progression in Indian Patients
    Bagchi, Soumita
    Upadhyay, Ashish Datt
    Barwad, Adarsh
    Singh, Geetika
    Subbiah, Arunkumar
    Yadav, Raj Kanwar
    Mahajan, Sandeep
    Bhowmik, Dipankar
    Agarwal, Sanjay Kumar
    KIDNEY INTERNATIONAL REPORTS, 2022, 7 (06): : 1210 - 1218
  • [22] Clinical Utility of the International Risk-Prediction Tool in Japanese Patients with IgA Nephropathy
    Kawamura, Sayumi
    Wada, Yukihiro
    Matsuzaki, Keiichi
    Abe, Tetsuya
    Tsutsumi, Akizumi
    Takeuchi, Yasuo
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (10):
  • [23] External Validation of Two New IgA Risk-Prediction Tools in a Norwegian Cohort
    Haaskjold, Yngvar Lunde
    Lura, Njal
    Bjoerneklett, Rune
    Bostad, Lars S.
    Knoop, Thomas
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 495 - 496
  • [24] Application of the International IgA Nephropathy Prediction Tool one or two years post-biopsy
    Barbour, Sean J.
    Coppo, Rosanna
    Zhang, Hong
    Liu, Zhi-Hong
    Suzuki, Yusuke
    Matsuzaki, Keiichi
    Er, Lee
    Reich, Heather N.
    Barratt, Jonathan
    Cattran, Daniel C.
    KIDNEY INTERNATIONAL, 2022, 102 (01) : 160 - 172
  • [25] External validation of the QLifetime cardiovascular risk prediction tool: population cohort study
    Livingstone, Shona
    Morales, Daniel R. R.
    Fleuriot, Jacques
    Donnan, Peter T. T.
    Guthrie, Bruce
    BMC CARDIOVASCULAR DISORDERS, 2023, 23 (01)
  • [26] External validation of the QLifetime cardiovascular risk prediction tool: population cohort study
    Shona Livingstone
    Daniel R. Morales
    Jacques Fleuriot
    Peter T. Donnan
    Bruce Guthrie
    BMC Cardiovascular Disorders, 23
  • [27] Validation Study of Oxford Classification of IgA Nephropathy in a Chinese Cohort
    Liang, S.
    Zeng, C.
    Phillips, S.
    Shyr, Y.
    Troyanov, S.
    Liu, Z-H
    Foga, A. B.
    MODERN PATHOLOGY, 2011, 24 : 347A - 347A
  • [28] Validation Study of Oxford Classification of IgA Nephropathy in a Chinese Cohort
    Liang, S.
    Zeng, C.
    Phillips, S.
    Shyr, Y.
    Troyanov, S.
    Liu, Z-H
    Fogo, A. B.
    LABORATORY INVESTIGATION, 2011, 91 : 347A - 347A
  • [29] A Validation Study Comparing Risk Prediction Models of IgA Nephropathy
    Ouyang, Yan
    Zhao, Zhanzheng
    Li, Guisen
    Luo, Huimin
    Xu, Feifei
    Shao, Leping
    Chen, Zijin
    Yu, Shuwen
    Jin, Yuanmeng
    Xu, Jing
    Shi, Manman
    Hussain, Hafiz Muhammad Jafar
    Du, Wen
    Fang, Zhengying
    Pan, Xiaoxia
    Wang, Weiming
    Xie, Jingyuan
    Chen, Nan
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [30] Lower baseline eGFR levels and IgA nephropathy prediction tool
    Artan, Ayse S.
    Mirioglu, Safak
    Demir, Erol
    Dirim, Ahmet B.
    Safak, Seda
    Garayeva, Nurana
    Ozluk, Yasemin
    Oto, Ozgur A.
    Yazici, Halil
    Caliskan, Yasar K.
    NEPHROLOGY, 2021, 26 (12) : 1026 - 1027
12345